GPR40, Not GPR120, Independently Predicts Overall Survival in mHSPC
This study identifies high tumor GPR40 expression as an independent adverse prognostic marker for overall survival in metastatic hormone-sensitive prostate cancer, whereas GPR120 expression, while associated with shorter survival in univariate analysis, lacks independent predictive value.